v3.26.1
Share-Based Payments: (Tables)
 3 Months Ended
Mar. 31, 2026
Equity:  
The following table sets forth information with respect to nonvested options for the three months ended March 31, 2026:

The following table sets forth information with respect to nonvested options for the March 31, 2026:

 

    Number of Shares     Weighted Average Grant-Date Fair Value  
Nonvested options at January 1, 2026     131,600     $ 26.83  
Nonvested options granted     —       —  
Nonvested options vested or forfeited     (2,000 )   $ 29.96  
Nonvested options at March 31, 2026     129,600     $ 26.78  
The following table summarizes stock option information as of March 31, 2026:

The following table summarizes stock option information as of March 31, 2026:

 

    Shares     Weighted Average
Exercise Price		  
             
Outstanding at January 1, 2026     187,050     $ 112.67  
Options forfeited     (2,900 )     126.33  
Options exercised     (4,500 )     62.18  
                 
Outstanding at March 31, 2026     179,650     $ 113.72  
                 
Options exercisable     50,050     $ 120.17  
Options available for future grants     410,380          
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2026 and 2025 were as follows:

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the March 31, 2026 and 2025 were as follows:

 

(In thousands)   March 31, 2026     March 31, 2025  
             
Cash proceeds from stock options exercised   $ 280     $ 1,077  
Tax benefits     20       125  
Intrinsic value of stock options exercised     160       840